Tag Archives: The Stem Cell Blog

What’s the deal with CRISPR? – McGill Tribune

Continue reading

2017-03-28 NEWS

McGill Tribune

What’s the deal with CRISPR?
McGill Tribune
CRISPR offers the potential to cure presently untreatable cancers and diseases. Moreover, it could revive an extinct organism, such as the mammoth, using tiny bits of genomic information that scientists have collected through their serendipitous
European Patent Office to Grant Broad Claims on Patent Covering CRISPR-Cas9 Gene Editing TechnologyBusiness Wire (press release)

all 3 news articles »

Continue reading

2017-03-28 NEWS

The Independent

Global Stem Cell Umbilical Cord Blood Market 2017 : Cryosite, Stemlife, Smart Cells, LifeCell, Cryolife
Medgadget (blog)
The Global Stem Cell Umbilical Cord Blood Market Key Vendors are Stemcyte Inc, Cell Care, Smart Cells, LifeCell, Cryolife, Healthbanks Biotech, StemOne Biologicals, Cryosite, Stemlife, cordlife, Cells for Life . The report, named “Global Stem Cell
The life cordDaily Pioneer
How umbilical cords are saving the lives of cancer patientsThe Independent

all 5 news articles »

Continue reading

2017-03-28 NEWS

New Tools to Study the Origin of Embryonic Stem Cells
Technology Networks
The blastocyst then attaches itself to the wall of the uterus (implantation), and for a limited period from fertilisation to a few days after implantation the embryo contains pluripotent stem cells. These cells can develop into all the body’s cell

and more »

Continue reading

2017-03-28 NEWS

Why did Biotech Beat Pharma to Bring the First Gene Therapy to Market?
Labiotech.eu (blog)
Pharma would seemingly best biotech in any competition. A few CEO’s explain why it left the honor of “The World’s First Gene Therapy” to biotech. On July 20, 2012, the world’s first gene therapy, Glybera, received marketing authorization from the EMA.

Continue reading

2017-03-28 NEWS

Why did Biotech Beat Pharma to Bring the First Gene Therapy to …
Labiotech.eu (blog)
Pharma would seemingly best biotech in any competition. A few CEO’s explain why it left the honor of “The World’s First Gene Therapy” to biotech.

and more »

Continue reading

2017-03-28 NEWS

From synthetic biology to global health challenges
University of Bristol
The new Bristol Biodesign Institute (BBI) builds on a £70 million investment in synthetic biology at the University, which includes a synthetic biology research centre and a centre for doctoral training. The BBI will be the focal point for